Anavex Life Sciences Corp (AVXL)

[XenaLives]

Top 20 pharma list revised:

(right click and open image in new tab if it's difficult to see)

The list is arranged by market cap, putting the giant conglomerate J&J on top. Celgene holds the bottom spot, which it will soon enough give up as Bristol-Myers closes its $74 billion acquisition deal. CSL is still right in the mix, as you can see, highlighting an Australian company that doesn’t get nearly enough attention.

https://endpts.com/the-corrected-list-of-the-worlds-top-20-pharma-companies/

CSL
Expertise
Rare and Serious Diseases

Rare and Serious Diseases

Our top priority is saving and improving the lives of our patients. CSL's commitment to enhancing the quality of life for people with rare and serious diseases around the globe is reflected in our support of programs and activities for patients with rare plasma-protein related diseases, including bleeding disorders, primary immune deficiencies and Alpha-1 proteinase inhibitor deficiencies.

We collaborate with patient advocacy groups, both disease-specific and umbrella organizations, to promote quality medical care and services. We aim to improve and expand educational and outreach efforts. Through these partnerships, we strive to raise public awareness and to enhance appropriate public policies for rare diseases.

https://www.csl.com/expertise/rare-and-serious-diseases